Evaxion A/S: Financial statements 2015
CVR: 31762863
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Evaxion A/S (CVR 31762863) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -5,082,775 and a net result of DKK -6,029,250 compared with DKK -1,518,749 the year before. Equity in the 2015 report amounted to DKK 13,018,435. The solvency ratio was 91.3%.
- Gross Profit
- DKK -5,082,775
- Profit/Loss
- DKK -6,029,250
- Equity
- DKK 13,018,435
- Total Assets
- DKK 14,257,447
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -5.1 mio. | -6 mio. | 13 mio. | - |
| 2014 | - | -399 t. | -1.5 mio. | 9.9 mio. | - |
| 2013 | - | 518 t. | 419 t. | 539 t. | - |
| 2012 | 1.4 mio. | - | 324 t. | 119 t. | - |
Official annual report
How creditworthy is Evaxion A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Evaxion A/S has published its annual report for 2014. Gross profit came to DKK -399,331, and the net result was DKK -1,518,749.
About Evaxion A/S
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 24 employees (2018). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.